What is an FDA Calendar? Biotech investing is risk-fraught, as stocks are at the mercy of several catalysts – most of which are make-or-break events, aka binary events. A prudent investment ...

There is an opportunity to fix this by encouraging regulators such as the FDA and the EMA to agree on an aligned regulatory approach to the development of complex generics. In 2021, the FDA and ...

1 strain of the virus. "Today's authorization provides an additional COVID-19 vaccine option," said Peter Marks, director of the FDA's Center for Biologics Evaluation and Research. Doses are on ...

Both Pfizer and Moderna’s shots target the KP.2 COVID-19 variant—JN.1 is the parent variant of KP.2. The FDA in June asked vaccine makers to create shots that target the coronavirus’ JN.

THE Tax Management Association of the Philippines (TMAP) will be hosting its first International Tax Summit at Makati Shangri-La on Aug. 29, 2024. The summit will feature discussions of various ...

The FDA has approved the combination of Rybrevant plus Lazcluze for first-line treatment of adult patients with locally advanced or metastatic non-small-cell lung cancer, or NSCLC, with epidermal ...

The FDA on Thursday said its marketing authorization of the product was its first ever for a over-the-counter hearing aid software device. Related Apple to release AirPods with built-in hearing ...

Cresilon has raised about $130 million in venture capital dollars and grown to comprise more than 80 employees — and last week, the company nabbed its second FDA clearance for human use.

Advertisement One week ago, the FDA approved the updated versions for Pfizer/BioNTech and Moderna, an mRAN. They are now available in some pharmacies. All these vaccines include a monovalent ...

THE Tax Management Association of the Philippines (TMAP) wrapped up a successful first International Tax Summit with a full day of discussions and conversations on local and international tax issues.

Democratic Reps. Ayanna Pressley of Massachusetts and Shontel Brown of Ohio pressed the FDA in a letter to finalize the proposed rule for banning certain salon-grade and at-home hair straighteners.